Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine 5% cream versus hydroquinone 4% cream for facial melasma
RBR-5khj37Completed
- Sponsor
- UNESP Botucatu Medical School
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cysteamine and hydroquinone in melasma (2 arms), sponsored by UNESP Botucatu Medical School. Started Oct 2019; status: completed.
02
Drugs
cysteaminehydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-5khj37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5khj37.